ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 648,74
1,11%
DAX
18 001,60
0,54%
Brent Oil
83,285
-0,41%
Bitcoin
61 682,22
4,33%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Eterna Therapeutics Inc (ERNA)

  7. Eterna Therapeutics Inc (ERNA) Actualités

ERNA Eterna Therapeutics Inc

1,72
0,01 (0,58%)
Dernière mise à jour : 15:53:08
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Eterna Therapeutics Inc ERNA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,58% 1,72 15:53:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,80 1,72 1,80 1,71
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
20/2/202414:30GLOBEEterna Therapeutics Announces the Appointment of Peter..
16/2/202423:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202413:30EDGAR2Form 8-K - Current report
31/1/202413:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202422:16EDGAR2Form 8-K - Current report
19/1/202416:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16/1/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202422:49EDGAR2Form S-3 - Registration statement under Securities Act of..
03/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202422:15GLOBEEterna Therapeutics Grants New President and CEO Sanjeev..
22/12/202318:05EDGAR2Form SC 13D/A - General statement of acquisition of..
20/12/202322:20EDGAR2Form 8-K - Current report
20/12/202322:15GLOBEEterna Therapeutics Names Sanjeev Luther as President and..
20/12/202321:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/12/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202303:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202300:56GLOBEEterna Therapeutics Announces $9.2 Million Convertible Debt..
14/12/202322:30EDGAR2Form 8-K - Current report
16/11/202322:16EDGAR2Form 8-K - Current report
13/11/202323:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/11/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202313:34EDGAR2Form 8-K - Current report
01/11/202313:30GLOBEEterna Therapeutics Appoints James Bristol, Ph.D.,..
05/10/202322:30EDGAR2Form 8-K - Current report
26/9/202322:30EDGAR2Form 8-K/A - Current report: [Amend]
08/9/202312:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/9/202323:26EDGAR2Form SC 13D/A - General statement of acquisition of..
06/9/202314:00GLOBEEterna Therapeutics Announces Initiation of Development..
05/9/202314:30GLOBEEterna Therapeutics Appoints Biopharma Industry Veteran..
01/9/202323:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/8/202322:15EDGAR2Form 8-K - Current report
28/8/202322:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/8/202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202313:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202322:59EDGAR2Form S-3 - Registration statement under Securities Act of..
11/8/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:10EDGAR2Form 8-K - Current report
02/8/202323:25EDGAR2Form 8-K - Current report
26/7/202323:05EDGAR2Form SC 13D/A - General statement of acquisition of..
18/7/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202314:05EDGAR2Form 8-K - Current report
18/7/202314:00GLOBEEterna Therapeutics Announces Completion of $8.7 Million of..
18/7/202312:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
ERNA
Eterna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés